Bavencio FDA
FDA approves Pfizer and Merck KGaA’s Bavencio for maintenance of advanced bladder cancer
July 1, 2020Research and Development, Sales and Marketing Bavencio FDA, EMD Serono, Merck, Pfier
The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
